← Back to Patent Explorer
US4072683A Expired / Lapsed US ⏱️ 0.0 years remaining

3,4-Dihydrocarbostyril derivatives

Assignee: Otsuka Pharmaceutical Co Ltd
•
Filing: 1975-11-10
•
Granted: 1978-02-07
•
Expires: 1995-11-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel (3'-alkylamino-2'-hydroxy)propoxy-3,4-dihydrocarbostyril derivatives having beta -adrenergic nerves blocking activity and hypotensive activity and useful as a remedy for angina pectoris, irregular pulse and hypertension, etc., represented by the formula, <IMAGE> wherein R1 is hydrogen, C1-C4 alkyl or aralkyl and R2 is C1-C4 alkyl, are prepared by reacting a 3,4-dihydrocarbostyril derivative represented by the formula, <IMAGE> wherein R1 is C1-C4 alkyl or aralkyl, with an epihalogenohydrin represented by the formula, <IMAGE> wherein X is halogen, reacting the resulting product with an alkylamine represented by the formula, R2 - NH2 wherein R2 is as defined above, and, if necessary, reducing the resulting product.

Inventors

  • 👤 Kazuyuki Nakagawa
  • 👤 Minoru Uchida
  • 👤 Hiroaki Oka

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 22:51
CPC Classifications
C; C07; C07D; C07D215/00; C07D215/02; C07D215/16; C07D215/20; C07D215/24; C07D215/26

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 36 words
A compound of the formula, ##STR21## wherein R 1 is hydrogen, C 1 -C 4 alkyl, benzyl or phenethyl and R 2 is C 1 -C 4 alkyl or a pharmaceutically acceptable acid addition salt thereof.
Claim 2
Dependent Claim 36 words
A compound of the formula, ##STR21## wherein R 1 is hydrogen, C 1 -C 4 alkyl, benzyl or phenethyl and R 2 is C 1 -C 4 alkyl or a pharmaceutically acceptable acid addition salt thereof.
Claim 3
Dependent Claim 9 words
5-(3'-tert-Butylamino-2'-hydroxy)propoxy-8-hydroxy-3,4-dihydrocarbostyril or a pharmaceutically acceptable acid addition salt thereof.
Claim 4
Dependent Claim 9 words
5-(3'-tert-Butylamino-2'-hydroxy)propoxy-8-hydroxy-3,4-dihydrocarbostyril or a pharmaceutically acceptable acid addition salt thereof.
Claim 5
Dependent Claim 9 words
5-(3'-Isopropylamino-2'-hydroxy)propoxy-8-hydroxy-3,4-dihydrocarbostyril or a pharmaceutically acceptable acid addition salt thereof.
Claim 6
Dependent Claim 9 words
5-(3'-Isopropylamino-2'-hydroxy)propoxy-8-hydroxy-3,4-dihydrocarbostyril or a pharmaceutically acceptable acid addition salt thereof.
Claim 7
Dependent Claim 7 words
5-(3'-sec-Butylamino-2'-hydroxy)propoxy-8-hydroxy-3,4-dihydrocarbostyril or a pharmaceutically acceptable salt thereof.
Claim 8
Dependent Claim 7 words
5-(3'-sec-Butylamino-2'-hydroxy)propoxy-8-hydroxy-3,4-dihydrocarbostyril or a pharmaceutically acceptable salt thereof.
Claim 9
Dependent Claim 9 words
5-(3'-tert-Butylamino-2'-hydroxy)propoxy-8-methoxy-3,4-dihydrocarbostyril or a pharmaceutically acceptable acid addition salt thereof.
Claim 10
Dependent Claim 9 words
5-(3'-tert-Butylamino-2'-hydroxy)propoxy-8-methoxy-3,4-dihydrocarbostyril or a pharmaceutically acceptable acid addition salt thereof.
Claim 11
Dependent Claim 9 words
5-(3'-tert-Butylamino-2'-hydroxy)propoxy-8-benzyloxy-3,4-dihydrocarbostyril or a pharmaceutically acceptable acid addition salt thereof.
Claim 12
Dependent Claim 9 words
5-(3'-tert-Butylamino-2'-hydroxy)propoxy-8-benzyloxy-3,4-dihydrocarbostyril or a pharmaceutically acceptable acid addition salt thereof.
Claim 13
Dependent Claim 9 words
5-(3'-Isopropylamino-2'-hydroxy)propoxy-8-benzyloxy-3,4-dihydrocarbostyril or a pharmaceutically acceptable acid addition salt thereof.
Claim 14
Dependent Claim 9 words
5-(3'-Isopropylamino-2'-hydroxy)propoxy-8-benzyloxy-3,4-dihydrocarbostyril or a pharmaceutically acceptable acid addition salt thereof.
Claim 15
Dependent Claim 9 words
5-(3'-sec-Butylamino-2'-hydroxy)propoxy-8-benzyloxy-3,4-dihydrocarbostyril or a pharmaceutically acceptable acid addition salt thereof.
Claim 16
Dependent Claim 9 words
5-(3'-sec-Butylamino-2'-hydroxy)propoxy-8-benzyloxy-3,4-dihydrocarbostyril or a pharmaceutically acceptable acid addition salt thereof.

References Cited (Backward Citations)

GB1058822A Cited
US3340266A Cited
NL6400510A Cited
JPS421182Y1 Cited
US3910924A Cited
US3919239A Cited
US3953456A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1981-02-06 1981-08-08 1982-02-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1985-02-06 1985-08-08 1986-02-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1989-02-06 1989-08-08 1990-02-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag